세계의 세포유전학 시장 규모 조사 : 제품별, 기술별, 용도별, 최종사용자별, 지역별 예측(2022-2032년)

The Global Cytogenetics Market is estimated to be valued at approximately USD 2.42 billion in 2023 and is expected to grow at a robust CAGR of 9.5% over the forecast period 2024-2032. Cytogenetics, the study of chromosomes in cell and tissue samples, plays a pivotal role in understanding genetic disorders and cancers. With its applications spanning personalized medicine, targeted cancer treatment, and beyond, cytogenetics has emerged as an essential tool in the field of biology and medicine. The utilization of techniques such as comparative genomic hybridization, fluorescence in situ hybridization, and karyotyping enables the detection of genetic abnormalities and the diagnosis of cancers, driving the demand for cytogenetic products such as kits, media, reagents, and instruments.

The Global Cytogenetics Market is primarily driven by the rising incidence of genetic disorders and cancer. Increasing focus on targeted cancer therapies, along with a growing aging population and a higher prevalence of chronic diseases, further accelerates market growth. However, the high cost of cytogenetic instruments poses a challenge to market expansion. On the other hand, the transition from fluorescence in situ hybridization to array-based technologies presents lucrative growth opportunities for the market.

The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. In 2023, North America accounted for the largest share of the cytogenetics market, driven by a well-established healthcare infrastructure and significant investments in research and development. Europe closely follows with substantial market share. Meanwhile, the Asia-Pacific region is poised to witness the fastest growth during the forecast period, fueled by increasing disposable incomes, rising awareness about genetic disorders, and the expanding healthcare sector.

Major market players included in this report are:

• Applied Spectral Imaging, Inc.
• Illumina, Inc.
• Abbott Laboratories
• Irvine Scientific
• OPKO Health, Inc.
• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• PerkinElmer, Inc.
• Sysmex Corporation
• Empire Genomics, LLC
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• MetaSystems
• Oxford Gene Technology
• CytoTest Inc.

The detailed segments and sub-segments of the market are explained below:

By Product:

• Consumables
• Instruments
• Software & Services

By Technique:

• Comparative Genomic Hybridization
• Fluorescence in Situ Hybridization
• Karyotyping
• Immunohistochemistry
• Others

By Application:

• Genetic Disorders
• Cancer
• Personalized Medicine
• Others

By End User:

• Clinical & Research Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic Research Institutes
• Others

By Region:

North America:

• U.S.
• Canada

Europe:

• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe

Asia Pacific:

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America:

• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• Saudi Arabia
• South Africa
• Rest of Middle East and Africa

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of the geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand-side and supply-side analysis of the market.

Table of Contents

Chapter 1. Global Cytogenetics Market Executive Summary

• 1.1. Global Cytogenetics Market Size & Forecast (2022- 2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product
  • 1.3.2. By Technique
  • 1.3.3. By Application
  • 1.3.4. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Cytogenetics Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory Frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Cytogenetics Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rising Incidence of Genetic Disorders and Cancer
  • 3.1.2. Increase in Focus on Targeted Cancer Treatment
• 3.2. Market Challenges
  • 3.2.1. High Cost of Cytogenetic Instruments
  • 3.2.2. Limited Awareness in Emerging Economies
• 3.3. Market Opportunities
  • 3.3.1. Transition to Array-Based Techniques
  • 3.3.2. Growth in Personalized Medicine

Chapter 4. Global Cytogenetics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top Investment Opportunity
• 4.4. Top Winning Strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Cytogenetics Market Size & Forecasts by Product 2022-2032

• 5.1. Segment Dashboard
• 5.2. Consumables
• 5.3. Instruments
• 5.4. Software & Services

Chapter 6. Global Cytogenetics Market Size & Forecasts by Technique 2022-2032

• 6.1. Segment Dashboard
• 6.2. Comparative Genomic Hybridization
• 6.3. Fluorescence in Situ Hybridization
• 6.4. Karyotyping
• 6.5. Immunohistochemistry
• 6.6. Others

Chapter 7. Global Cytogenetics Market Size & Forecasts by Application 2022-2032

• 7.1. Segment Dashboard
• 7.2. Genetic Disorders
• 7.3. Cancer
• 7.4. Personalized Medicine
• 7.5. Others

Chapter 8. Global Cytogenetics Market Size & Forecasts by End User 2022-2032

• 8.1. Segment Dashboard
• 8.2. Clinical & Research Laboratories
• 8.3. Pharmaceutical & Biotechnology
• 8.4. Academic Research Institutes
• 8.5. Others

Chapter 9. Global Cytogenetics Market Size & Forecasts by Region 2022-2032

• 9.1. North America Cytogenetics Market
  • 9.1.1. U.S. Cytogenetics Market
    • 9.1.1.1. By Product breakdown size & forecasts, 2022-2032
    • 9.1.1.2. By Technique breakdown size & forecasts, 2022-2032
    • 9.1.1.3. By Application breakdown size & forecasts, 2022-2032
    • 9.1.1.4. By End User breakdown size & forecasts, 2022-2032
  • 9.1.2. Canada Cytogenetics Market
• 9.2. Europe Cytogenetics Market
  • 9.2.1. U.K. Cytogenetics Market
  • 9.2.2. Germany Cytogenetics Market
  • 9.2.3. France Cytogenetics Market
  • 9.2.4. Italy Cytogenetics Market
  • 9.2.5. Spain Cytogenetics Market
  • 9.2.6. Rest of Europe Cytogenetics Market
• 9.3. Asia-Pacific Cytogenetics Market
  • 9.3.1. China Cytogenetics Market
  • 9.3.2. India Cytogenetics Market
  • 9.3.3. Japan Cytogenetics Market
  • 9.3.4. Australia Cytogenetics Market
  • 9.3.5. South Korea Cytogenetics Market
  • 9.3.6. Rest of Asia-Pacific Cytogenetics Market
• 9.4. Latin America Cytogenetics Market
  • 9.4.1. Brazil Cytogenetics Market
  • 9.4.2. Mexico Cytogenetics Market
  • 9.4.3 Rest of Latin America Cytogenetics Market
• 9.5. Middle East and Africa Cytogenetics Market
  • 9.4.2. Saudi Arabia Cytogenetics Market
  • 9.4.3. South Africa Cytogenetics Market
  • 9.4.4. Rest of Middle East and Africa Cytogenetics Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Applied Spectral Imaging, Inc.
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Market Strategies
  • 10.3.2. Illumina, Inc.
  • 10.3.3. Abbott Laboratories
  • 10.3.4. Irvine Scientific
  • 10.3.5. OPKO Health, Inc.
  • 10.3.6. Thermo Fisher Scientific, Inc.
  • 10.3.7. Agilent Technologies, Inc.
  • 10.3.8. PerkinElmer, Inc.
  • 10.3.9. Sysmex Corporation
  • 10.3.10. Empire Genomics, LLC
  • 10.3.11. Bio-Rad Laboratories, Inc.
  • 10.3.12. F. Hoffmann-La Roche Ltd.
  • 10.3.13. MetaSystems
  • 10.3.14. Oxford Gene Technology
  • 10.3.15. CytoTest Inc.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes